Revenue by segment/product/region: Other
Flow – sum over the period · $M
Q4 FY2025
542a$M
derived
All values (31)
| Period | Value ($M) | Status |
|---|---|---|
| Q4 FY2025 | 542 | derived |
| Q3 FY2025 | 565 | reported |
| Q2 FY2025 | 561 | reported |
| Q1 FY2025 | 548 | reported |
| Q4 FY2024 | 539 | derived |
| Q3 FY2024 | 579 | reported |
| Q2 FY2024 | 597 | reported |
| Q1 FY2024 | 605 | reported |
| Q4 FY2023 | 595 | derived |
| Q3 FY2023 | 604 | reported |
| Q2 FY2023 | 577 | reported |
| Q1 FY2023 | 555 | reported |
| Q4 FY2022 | 498 | derived |
| Q3 FY2022 | 484 | reported |
| Q2 FY2022 | 426 | reported |
| Q1 FY2022 | 427 | reported |
| Q4 FY2021 | 341 | derived |
| Q3 FY2021 | 334 | reported |
| Q2 FY2021 | 311 | reported |
| Q1 FY2021 | 290 | reported |
| Q4 FY2020 | 288 | derived |
| Q3 FY2020 | 274 | reported |
| Q2 FY2020 | 252 | reported |
| Q1 FY2020 | 241 | reported |
| Q4 FY2019 | 228 | derived |
| Q3 FY2019 | 224 | reported |
| Q2 FY2019 | 221 | reported |
| Q1 FY2019 | 196 | reported |
| Q4 FY2018 | 197 | derived |
| Q3 FY2018 | 195 | reported |
| Q2 FY2018 | 194 | reported |
15 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: seg_revenue / crm:ProfessionalServicesandOtherMember
More metrics for Salesforce
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Sources & calculation
- Value
- $542M (derived)
- Period
- Q4 FY2025, ended Jan 31, 2025 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = 2,216M − 1,674M = $542M (FY value from 10-K 0001108524-26-000060; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Mar 2, 2026 · 0001108524-26-000060
- Location
- us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax [srt:ProductOrServiceAxis=crm:ProfessionalServicesandOtherMember]
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $542M | Mar 2, 2026 | 10-K 0001108524-26-000060 | derived · confidence 1. · current |